C
39.02
-0.20 (-0.51%)
| Previous Close | 39.22 |
| Open | 39.24 |
| Volume | 10,406,818 |
| Avg. Volume (3M) | 9,546,614 |
| Market Cap | 19,179,032,576 |
| Price / Earnings (Forward) | 15.24 |
| Price / Sales | 0.120 |
| Price / Book | 1.07 |
| 52 Weeks Range | |
| Earnings Date | 29 Oct 2025 |
| Profit Margin | 2.25% |
| Operating Margin (TTM) | 4.49% |
| Diluted EPS (TTM) | 6.78 |
| Quarterly Revenue Growth (YOY) | 16.60% |
| Quarterly Earnings Growth (YOY) | 12.70% |
| Total Debt/Equity (MRQ) | 65.38% |
| Current Ratio (MRQ) | 1.11 |
| Operating Cash Flow (TTM) | 2.12 B |
| Levered Free Cash Flow (TTM) | 2.51 B |
| Return on Assets (TTM) | 3.86% |
| Return on Equity (TTM) | 12.53% |
Market Trend
| Short Term | Medium Term | ||
| Industry | Healthcare Plans (US) | Bullish | Bearish |
| Healthcare Plans (Global) | Bullish | Bearish | |
| Stock | Centene Corporation | Bullish | Bearish |
AIStockmoo Score
1.6
| Analyst Consensus | 1.5 |
| Insider Activity | 3.0 |
| Price Volatility | -2.0 |
| Technical Moving Averages | 3.5 |
| Technical Oscillators | 2.0 |
| Average | 1.60 |
|
Centene is a managed care organization that focuses on government-sponsored healthcare plans, including Medicaid, Medicare, and the individual exchanges. Centene served 22 million medical members as of December 2024, mostly in Medicaid (about 60% of membership), the individual exchanges (about 20%), and Medicare (about 5%). The company also has a military contract and provides Medicare Part D pharmaceutical plans. |
|
| Sector | Healthcare |
| Industry | Healthcare Plans |
| Investment Style | Mid Value |
| % Held by Insiders | 0.46% |
| % Held by Institutions | 99.81% |
Ownership
| Name | Date | Shares Held |
|---|---|---|
| Politan Capital Management Lp | 30 Sep 2025 | 7,409,084 |
| 52 Weeks Range | ||
| Price Target Range | ||
| High | 54.00 (Barclays, 38.39%) | Buy |
| Median | 41.50 (6.36%) | |
| Low | 34.00 (TD Cowen, -12.87%) | Hold |
| Average | 41.80 (7.13%) | |
| Total | 3 Buy, 6 Hold, 1 Sell | |
| Avg. Price @ Call | 37.55 | |
| Firm | Date | Target Price | Call | Price @ Call |
|---|---|---|---|---|
| Wells Fargo | 07 Jan 2026 | 43.00 (10.20%) | Hold | 45.93 |
| 12 Nov 2025 | 35.00 (-10.30%) | Hold | 36.20 | |
| Barclays | 05 Jan 2026 | 54.00 (38.39%) | Buy | 44.68 |
| 04 Nov 2025 | 44.00 (12.76%) | Hold | 36.11 | |
| Bernstein | 21 Nov 2025 | 45.00 (15.33%) | Buy | 36.50 |
| JP Morgan | 04 Nov 2025 | 38.00 (-2.61%) | Hold | 36.11 |
| Goldman Sachs | 31 Oct 2025 | 38.00 (-2.61%) | Sell | 35.37 |
| 14 Oct 2025 | 33.00 (-15.43%) | Sell | 36.44 | |
| TD Cowen | 31 Oct 2025 | 34.00 (-12.87%) | Hold | 35.37 |
| Cantor Fitzgerald | 30 Oct 2025 | 41.00 (5.07%) | Hold | 35.02 |
| Truist Securities | 30 Oct 2025 | 45.00 (15.33%) | Buy | 35.02 |
| UBS | 30 Oct 2025 | 42.00 (7.64%) | Hold | 35.02 |
| Morgan Stanley | 14 Oct 2025 | 38.00 (-2.61%) | Hold | 36.44 |
| Show more | ||||
| Name | Avg. Buy ($) | Avg. Sell ($) | Net Quantity | Net Value ($) |
|---|---|---|---|---|
| BURDICK KENNETH A | 41.15 | - | 729 | 29,998 |
| COUGHLIN CHRISTOPHER J | 41.15 | - | 729 | 29,998 |
| EPPINGER FREDERICK H | 41.15 | - | 608 | 25,019 |
| SAMUELS THEODORE R. II | 41.15 | - | 608 | 25,019 |
| TANJI KENNETH | 41.15 | - | 790 | 32,509 |
| Aggregate Net Quantity | 3,464 | |||
| Aggregate Net Value ($) | 142,544 | |||
| Aggregate Avg. Buy ($) | 41.15 | |||
| Aggregate Avg. Sell ($) | - | |||
| Name | Holder | Date | Type | Quantity | Price | Value ($) |
|---|---|---|---|---|---|---|
| COUGHLIN CHRISTOPHER J | Director | 31 Dec 2025 | Acquired (+) | 729 | 41.15 | 29,998 |
| BURDICK KENNETH A | Director | 31 Dec 2025 | Acquired (+) | 729 | 41.15 | 29,998 |
| EPPINGER FREDERICK H | Director | 31 Dec 2025 | Acquired (+) | 608 | 41.15 | 25,019 |
| SAMUELS THEODORE R. II | Director | 31 Dec 2025 | Acquired (+) | 608 | 41.15 | 25,019 |
| TANJI KENNETH | Director | 31 Dec 2025 | Acquired (+) | 790 | 41.15 | 32,509 |
The support, resistance and trendline levels presented has been generated by an artificial intelligence (AI) model and should be interpreted with caution.
Portfolio
| Realized Profit | - |
| Unrealized Profit | - |
| Dividend Received 2026 | - |
| Total Profit | - |
| Avg. Return | - |
| Quantity (Buy) | - |
| Avg. Price (Buy) | - |
| Quantity (Sold) | - |
| Avg. Price (Sold) | - |